Category:
Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients
August, 2020
In this analysis we aimed to describe Brazilian inflammatory bowel disease (IBD) patients’ knowledge and perceptions regarding biosimilars and compare with viewpoints from non-Brazilian patients.